We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+10.65%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$63.8B
AUM Growth
+$3.93B
(+6.6%)
Cap. Flow
-$1.01B
Cap. Flow
% of AUM
-1.58%
Top 10 Holdings %
Top 10 Hldgs %
22.75%
Holding
3,125
New
60
Increased
388
Reduced
2,521
Closed
139
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Match Group
MTCH
|
+$20M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$11.8M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$11.8M |
| 4 |
Caesars Entertainment
CZR
|
+$11.1M |
| 5 |
PROG Holdings
PRG
|
+$11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$59.2M |
| 2 |
PPLI
People Inc
PPLI
|
+$24.6M |
| 3 |
CZR
Caesars Entertainment Corporation
CZR
|
+$19.1M |
| 4 |
Teradyne
TER
|
+$16.1M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
+$15.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.2% |
| 2 | Healthcare | 13.87% |
| 3 | Financials | 12.55% |
| 4 | Consumer Discretionary | 11.87% |
| 5 | Communication Services | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1551
Usana Health Sciences
USNA
$286M
| $2.51M | ﹤0.01% |
34,081
-3,642
| -10% | -$292K |
|
|
CIM
1552
Chimera Investment
CIM
$1B
| $2.5M | ﹤0.01% |
101,506
-14,029
| -12% | -$374K |
|
1553
Universal Corp
UVV
$1.27B
| $2.49M | ﹤0.01% |
59,511
-8,589
| -13% | -$368K |
|
1554
Spectrum Brands
SPB
$2.07B
| $2.49M | ﹤0.01% |
43,560
-1,114
| -2% | -$61.1K |
|
1555
Workiva
WK
$3.54B
| $2.49M | ﹤0.01% |
44,629
-11,035
| -20% | -$614K |
|
|
ALLK
1556
DELISTED
Allakos
ALLK
| $2.47M | ﹤0.01% |
30,317
-6,055
| -17% | -$492K |
|
1557
Axsome Therapeutics
AXSM
$10.9B
| $2.47M | ﹤0.01% |
34,659
-9,260
| -21% | -$722K |
|
1558
OraSure Technologies
OSUR
$279M
| $2.46M | ﹤0.01% |
202,433
-14,235
| -7% | -$195K |
|
|
ONEM
1559
DELISTED
1Life Healthcare
ONEM
| $2.46M | ﹤0.01% |
86,784
+55,563
| +178% | +$1.75M |
|
|
PINC
1560
DELISTED
Premier
PINC
| $2.44M | ﹤0.01% |
74,409
+2,998
| +4% | +$99.6K |
|
1561
CEVA Inc
CEVA
$1.08B
| $2.44M | ﹤0.01% |
62,023
-3,249
| -5% | -$129K |
|
|
SWAV
1562
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $2.44M | ﹤0.01% |
32,154
-6,660
| -17% | -$378K |
|
1563
Allogene Therapeutics
ALLO
$694M
| $2.42M | ﹤0.01% |
64,164
-11,826
| -16% | -$446K |
|
|
MDLA
1564
DELISTED
Medallia, Inc.
MDLA
| $2.42M | ﹤0.01% |
88,199
-2,027
| -2% | -$61.5K |
|
1565
ArcBest
ARCB
$3.08B
| $2.41M | ﹤0.01% |
77,688
-4,837
| -6% | -$151K |
|
1566
TechnipFMC
FTI
$27.3B
| $2.41M | ﹤0.01% |
513,733
+17,511
| +4% | +$98.4K |
|
1567
Heritage Financial
HFWA
$1.21B
| $2.41M | ﹤0.01% |
131,060
-2,355
| -2% | -$46.1K |
|
|
INOV
1568
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
| $2.4M | ﹤0.01% |
90,876
-13,514
| -13% | -$316K |
|
1569
Ambarella
AMBA
$3.81B
| $2.4M | ﹤0.01% |
46,051
-12,873
| -22% | -$623K |
|
|
DCPH
1570
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $2.4M | ﹤0.01% |
46,748
-10,560
| -18% | -$517K |
|
1571
National Bank Holdings
NBHC
$1.9B
| $2.39M | ﹤0.01% |
91,187
-6,588
| -7% | -$181K |
|
|
RAVN
1572
DELISTED
Raven Industries Inc
RAVN
| $2.39M | ﹤0.01% |
111,174
-8,068
| -7% | -$186K |
|
1573
Southside Bancshares
SBSI
$967M
| $2.39M | ﹤0.01% |
97,766
-7,136
| -7% | -$193K |
|
|
TRHC
1574
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $2.39M | ﹤0.01% |
58,583
-3,094
| -5% | -$154K |
|
|
VSLR
1575
DELISTED
VIVINT SOLAR, INC.
VSLR
| $2.38M | ﹤0.01% |
56,272
-14,181
| -20% | -$366K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2020 Portfolio in Review
As of Q3 2020, RhumbLine Advisers held 3,125 positions worth $63.8B, up 6.6% from $59.9B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
RhumbLine Advisers's Q3 2020 filing shows 60 new, 388 increased, 2,521 reduced and 139 closed positions. Its largest new stake was PROG Holdings: 245,531 shares worth $11.8M. The largest sale was Apple, an estimated $59.2M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- RhumbLine Advisers's largest Q3 2020 buy was PROG Holdings: 245,531 shares worth $11.8M.
- RhumbLine Advisers added most to Match Group in Q3 2020, an estimated $20M increase.
- RhumbLine Advisers's biggest Q3 2020 reduction was Apple, cutting an estimated $59.2M.
- RhumbLine Advisers fully exited Caesars Entertainment Corporation in Q3 2020, selling an estimated $19.1M.
- RhumbLine Advisers's ten largest holdings make up 23% of its $63.8B portfolio in Q3 2020.
- RhumbLine Advisers opened 60 new positions and closed 139 in Q3 2020.
- RhumbLine Advisers's portfolio value rose 6.6% quarter-over-quarter to $63.8B.
Based on RhumbLine Advisers's 13F filing for Q3 2020, filed 12 Nov 2020.